(+)-alpha-Bisabolol decreases activity EXP 6480464 bisabolol results in decreased activity of CYP2B1 protein CTD PMID:15936245 (+)-artemisinin increases expression EXP 6480464 artemisinin results in increased expression of CYP2B1 mRNA CTD PMID:16919048 and PMID:36356836 (+)-isoborneol increases expression EXP 6480464 isoborneol results in increased expression of CYP2B1 mRNA CTD PMID:27889497 (-)-cotinine increases abundance EXP 6480464 CYP2B1 protein results in increased abundance of Cotinine CTD PMID:10799646 (-)-cotinine multiple interactions EXP 6480464 [Nicotine results in increased expression of CYP2B1 protein] which results in increased abundance of Cotinine CTD PMID:10799646 (R)-camphor decreases activity EXP 6480464 Camphor results in decreased activity of CYP2B1 protein CTD PMID:9242356 (S)-nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 2 more ... CTD PMID:10799646 more ... (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of CYP2B1 mRNA and Nicotine results in increased expression of CYP2B1 protein CTD PMID:10799646 and PMID:14972772 (S)-nicotine increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Nicotine CTD PMID:10799646 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases hydroxylation EXP 6480464 CYP2B1 protein results in increased hydroxylation of 1 more ... CTD PMID:12167570 1,2,4,5-tetrachlorobenzene increases expression EXP 6480464 1 more ... CTD PMID:10696772 1,2-dichloroethene affects expression EXP 6480464 1 and 2-dichloroethylene affects the expression of CYP2B1 protein CTD PMID:9493318 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CYP2B1 mRNA CTD PMID:32387197 1,4-benzoquinone affects expression EXP 6480464 quinone affects the expression of CYP2B1 protein CTD PMID:10462055 1,4-dichlorobenzene increases expression EXP 6480464 4-dichlorobenzene results in increased expression of CYP2B1 protein CTD PMID:9325029 1,4-dioxane multiple interactions EXP 6480464 1 and 4-dioxane results in increased expression of and results in increased activity of CYP2B1 protein CTD PMID:15490126 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CYP2B1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Ethinyl Estradiol CTD PMID:16485904 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with NADP] results in decreased activity of CYP2B1 protein CTD PMID:11805216 and PMID:16485904 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of CYP2B1 protein CTD PMID:15178696 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP2B1 mRNA CTD PMID:7513451 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP2B1 mRNA CTD PMID:32145629 and PMID:35192832 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CYP2B1 protein CTD PMID:32145629 19-Nor-17alpha-pregn-5(10)-en-20-yne-3alpha,17beta-diol increases expression EXP 6480464 17alpha-ethynylestr-5(10)-ene-3alpha and 17beta-diol results in increased expression of CYP2B1 mRNA CTD PMID:7513451 2,2',3,3',6,6'-hexachlorobiphenyl increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:22026639 2,2',4,4',5,5'-hexachlorobiphenyl increases activity EXP 6480464 2 more ... CTD PMID:1372805 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:15223772 and PMID:23770461 2,2',4,4',5,5'-hexachlorobiphenyl increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to 2 more ... CTD PMID:10640525 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:17160104 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:16107549 more ... 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 [CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,2',5,5'-tetrachlorobiphenyl increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to 2 more ... CTD PMID:10640525 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23770461 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [2 more ... CTD PMID:23770461 2,3',4,4',5-Pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:17342196 2,3',4,4',5-Pentachlorobiphenyl increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of 2 more ... CTD PMID:27208082 2,3,4,3',4'-Pentachlorobiphenyl increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to 2 more ... CTD PMID:10640525 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2B1 mRNA CTD PMID:16054898 and PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2B1 mRNA CTD PMID:28433708 and PMID:33387578 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions EXP 6480464 [CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:16107549 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of CYP2B1 mRNA and Butylated Hydroxytoluene results in increased expression of CYP2B1 protein CTD PMID:15110098 2-acetamidofluorene decreases expression EXP 6480464 2-Acetylaminofluorene analog results in decreased expression of CYP2B1 protein and 2-Acetylaminofluorene results in decreased expression of CYP2B1 protein CTD PMID:15916741 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CYP2B1 protein CTD PMID:10445401 2-Oxohexane increases activity EXP 6480464 Methyl n-Butyl Ketone results in increased activity of CYP2B1 protein CTD PMID:1372805 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of CYP2B1 protein CTD PMID:12806184 3,3',4,4',5-pentachlorobiphenyl increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to 3 more ... CTD PMID:10640525 3,3',4,4',5-pentachlorobiphenyl increases activity EXP 6480464 3 more ... CTD PMID:16628245 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:17160104 more ... 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of CYP2B1 protein CTD PMID:24278553 3,3',5,5'-tetrabromobisphenol A affects expression EXP 6480464 tetrabromobisphenol A affects the expression of CYP2B1 mRNA CTD PMID:26988606 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP 6480464 [tetrabromobisphenol A results in increased expression of CYP2B1 protein] which results in increased abundance of Reactive Oxygen Species CTD PMID:24278553 3,3'-diindolylmethane increases expression EXP 6480464 3 and 3'-diindolylmethane results in increased expression of CYP2B1 protein CTD PMID:8384853 3-methylbenzyl alcohol decreases activity EXP 6480464 3-methylbenzyl alcohol results in decreased activity of CYP2B1 protein CTD PMID:12791539 3-methylcholanthrene multiple interactions EXP 6480464 Methylcholanthrene promotes the reaction [Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP2B1 protein] CTD PMID:18486174 3-methylcholanthrene affects expression EXP 6480464 Methylcholanthrene affects the expression of CYP2B1 mRNA CTD PMID:23273579 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases activity EXP 6480464 musk ketone results in increased activity of CYP2B1 protein CTD PMID:10630706 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression EXP 6480464 musk ketone results in increased expression of CYP2B1 mRNA and musk ketone results in increased expression of CYP2B1 protein CTD PMID:10630706 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CYP2B1 mRNA CTD PMID:30723492 4,4'-methylene-bis-(2-chloroaniline) increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of Methylenebis(chloroaniline) CTD PMID:2908851 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases activity EXP 6480464 CYP2B1 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:10799646 4-Vinylcyclohexene multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of 4-vinylcyclohexene] which results in increased abundance of 1 and 2-epoxy-4-vinylcyclohexane CTD PMID:11368546 4-Vinylcyclohexene increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of 4-vinylcyclohexene CTD PMID:11368546 5,5-diethylbarbituric acid increases activity EXP 6480464 Barbital results in increased activity of CYP2B1 protein CTD PMID:7697745 5,7-dihydroxy-4'-methoxyflavone decreases activity EXP 6480464 acacetin results in decreased activity of CYP2B1 protein CTD PMID:32738202 5-fluorouracil multiple interactions EXP 6480464 [CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil] and [CYP2B1 co-treated with CDA] results in increased susceptibility to Fluorouracil CTD PMID:10811482 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP2B1 mRNA and Omeprazole results in increased expression of CYP2B1 protein CTD PMID:19118567 and PMID:9152597 7,12-dimethyltetraphene increases activity EXP 6480464 9 more ... CTD PMID:16054776 7,12-dimethyltetraphene multiple interactions EXP 6480464 beta-Naphthoflavone inhibits the reaction [9 more ... CTD PMID:16054776 acetone decreases expression EXP 6480464 Acetone results in decreased expression of CYP2B1 protein CTD PMID:8267643 acetonitrile multiple interactions EXP 6480464 acetonitrile inhibits the reaction [CYP2B1 protein results in increased metabolism of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19858067 aflatoxin B1 multiple interactions EXP 6480464 CYP2B1 protein affects the metabolism of and results in increased activity of Aflatoxin B1 CTD PMID:10357798 aflatoxin B1 increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to Aflatoxin B1 CTD PMID:2125692 alachlor multiple interactions EXP 6480464 alachlor results in increased expression of and results in increased activity of CYP2B1 protein CTD PMID:11850968 allyl alcohol increases expression EXP 6480464 allyl alcohol results in increased expression of CYP2B1 protein CTD PMID:10445401 alpha-hexachlorocyclohexane multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased activity of CYP2B1 protein more ... CTD PMID:11165752 and PMID:16246485 alpha-hexachlorocyclohexane increases activity EXP 6480464 alpha-hexachlorocyclohexane results in increased activity of CYP2B1 protein CTD PMID:1372805 alpha-pinene decreases activity EXP 6480464 alpha-pinene results in decreased activity of CYP2B1 protein CTD PMID:9242356 amitraz increases expression EXP 6480464 amitraz results in increased expression of CYP2B1 protein CTD PMID:15350676 and PMID:31029719 amitriptyline increases expression EXP 6480464 Amitriptyline results in increased expression of CYP2B1 mRNA CTD PMID:10945841 amitrole multiple interactions EXP 6480464 Amitrole inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:11353799 and PMID:14722249 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP2B1 mRNA CTD PMID:16483693 aniline multiple interactions EXP 6480464 [Phenobarbital results in increased expression of CYP2B1 protein] which results in increased metabolism of aniline CTD PMID:9010585 Aroclor 1254 increases activity EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased activity of CYP2B1 protein CTD PMID:8471063 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2B1 mRNA and Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2B1 protein CTD PMID:11163329 and PMID:8471063 aspartame multiple interactions EXP 6480464 Aspartame results in increased expression of and results in increased activity of CYP2B1 protein CTD PMID:16937917 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of CYP2B1 gene CTD PMID:35440735 barbiturates increases activity EXP 6480464 Barbiturates results in increased activity of CYP2B1 protein CTD PMID:1372805 benzene increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Benzene CTD PMID:8211999 benzene increases expression EXP 6480464 Benzene results in increased expression of CYP2B1 protein CTD PMID:8135039 and PMID:9010585 benzene multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone more ... CTD PMID:8211999 and PMID:9118895 benzo[a]pyrene multiple interactions EXP 6480464 [3-xylene results in decreased activity of CYP2B1 protein] which affects the metabolism of Benzo(a)pyrene and [Phenobarbital co-treated with Benzo(a)pyrene] results in increased expression of CYP2B1 mRNA CTD PMID:1949897 and PMID:25489928 benzophenone increases expression EXP 6480464 benzophenone results in increased expression of CYP2B1 and benzophenone results in increased expression of CYP2B1 mRNA CTD PMID:14613717 and PMID:22584684 beta-myrcene decreases activity EXP 6480464 beta-myrcene results in decreased activity of CYP2B1 protein CTD PMID:9242356 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP2B1 mRNA and beta-Naphthoflavone results in increased expression of CYP2B1 protein CTD PMID:15588932 and PMID:15607757 beta-naphthoflavone increases activity EXP 6480464 beta-Naphthoflavone results in increased activity of CYP2B1 protein CTD PMID:16054776 beta-naphthoflavone multiple interactions EXP 6480464 beta-Naphthoflavone inhibits the reaction [9 more ... CTD PMID:16054776 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of CYP2B1 mRNA CTD PMID:23292798 bilobalide increases expression EXP 6480464 bilobalide results in increased expression of CYP2B1 mRNA and bilobalide results in increased expression of CYP2B1 protein CTD PMID:16258077 and PMID:18421621 biphenyl-4-amine increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of 4-biphenylamine CTD PMID:2908851 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP2B1 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP2B1 mRNA CTD PMID:32145629 and PMID:35192832 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP2B1 protein CTD PMID:32145629 bitertanol increases expression EXP 6480464 bitertanol results in increased expression of CYP2B1 protein CTD PMID:16971034 bromodichloromethane increases expression EXP 6480464 bromodichloromethane results in increased expression of CYP2B1 protein CTD PMID:11295256 bromodichloromethane increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of bromodichloromethane CTD PMID:11295256 and PMID:12076521 bromodichloromethane decreases expression EXP 6480464 bromodichloromethane results in decreased expression of CYP2B1 protein CTD PMID:11295256 bromuconazole decreases expression EXP 6480464 bromuconazole results in decreased expression of CYP2B1 CTD PMID:28532222 brucine increases expression EXP 6480464 brucine results in increased expression of CYP2B1 protein CTD PMID:7906730 bupropion increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Bupropion CTD PMID:28438436 bupropion multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Bupropion] which results in increased chemical synthesis of hydroxybupropion CTD PMID:28438436 Butylbenzyl phthalate decreases activity EXP 6480464 butylbenzyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 Butylparaben decreases activity EXP 6480464 butylparaben results in decreased activity of CYP2B1 protein CTD PMID:27432241 C.I. Natural Red 20 decreases activity EXP 6480464 shikonin results in decreased activity of CYP2B1 protein CTD PMID:28941798 camphor decreases activity EXP 6480464 Camphor results in decreased activity of CYP2B1 protein CTD PMID:9242356 carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of CYP2B1 mRNA CTD PMID:16125621 carbon monoxide multiple interactions EXP 6480464 Carbon Monoxide inhibits the reaction [CYP2B1 protein results in increased reduction of sodium chromate(VI)] CTD PMID:1903091 chloral hydrate multiple interactions EXP 6480464 Chloral Hydrate inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:7513451 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of CYP2B1 mRNA CTD PMID:7513451 chlordecone multiple interactions EXP 6480464 Chlordecone inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:7513451 chlorobenzene multiple interactions EXP 6480464 [Phenobarbital results in increased expression of CYP2B1 protein] which results in increased metabolism of chlorobenzene CTD PMID:9010585 chlorpyrifos decreases activity EXP 6480464 Chlorpyrifos results in decreased activity of CYP2B1 protein CTD PMID:15587241 chlorpyrifos affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Chlorpyrifos CTD PMID:15587241 chlorzoxazone affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Chlorzoxazone CTD PMID:15879494 choline multiple interactions EXP 6480464 Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP2B1 protein] and Choline deficiency promotes the reaction [Phenobarbital results in increased expression of CYP2B1 protein] CTD PMID:18798224 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of CYP2B1 mRNA CTD PMID:27225895 and PMID:7587954 ciprofibrate multiple interactions EXP 6480464 pyridine promotes the reaction [ciprofibrate results in increased expression of CYP2B1 protein] CTD PMID:7587954 citral decreases activity EXP 6480464 citral results in decreased activity of CYP2B1 protein CTD PMID:9242356 citronellal decreases activity EXP 6480464 citronellal results in decreased activity of CYP2B1 protein CTD PMID:9242356 climbazole increases expression EXP 6480464 climbazole results in increased expression of CYP2B1 mRNA and climbazole results in increased expression of CYP2B1 protein CTD PMID:11552297 and PMID:11824557 clofibrate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibrate] results in increased expression of CYP2B1 protein and Clofibrate promotes the reaction [CYP2B1 protein results in increased oxidation of Thiotepa] CTD PMID:10550479 and PMID:2105156 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP2B1 mRNA CTD PMID:11328961 more ... clofibric acid multiple interactions EXP 6480464 [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B1 protein] more ... CTD PMID:15788368 clofibric acid increases expression EXP 6480464 Clofibric Acid results in increased expression of CYP2B1 mRNA CTD PMID:15788368 clonazepam increases activity EXP 6480464 Clonazepam results in increased activity of CYP2B1 protein CTD PMID:1372805 clotrimazole multiple interactions EXP 6480464 Clotrimazole inhibits the reaction [CYP2B1 protein results in increased metabolism of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19858067 clotrimazole increases activity EXP 6480464 Clotrimazole results in increased activity of CYP2B1 protein CTD PMID:1372805 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of CYP2B1 mRNA and Clotrimazole results in increased expression of CYP2B1 protein CTD PMID:36356836 and PMID:7986207 corticosterone multiple interactions EXP 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B1 protein] CTD PMID:35301062 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CYP2B1 mRNA and Corticosterone results in increased expression of CYP2B1 protein CTD PMID:35301062 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of CYP2B1 mRNA and Hydrocortisone results in increased expression of CYP2B1 protein CTD PMID:10476907 cumene hydroperoxide affects oxidation EXP 6480464 CYP2B1 protein affects the oxidation of cumene hydroperoxide CTD PMID:17478480 curcumin affects expression EXP 6480464 Curcumin affects the expression of CYP2B1 protein CTD PMID:16805852 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [CYP2B1 protein results in increased metabolism of nitrosobenzylmethylamine] CTD PMID:16805852 cyclophosphamide multiple interactions EXP 6480464 Cyclophosphamide results in increased expression of and results in increased activity of CYP2B1 protein and Metyrapone inhibits the reaction [CYP2B1 results in increased susceptibility to Cyclophosphamide] CTD PMID:16019949 and PMID:7834628 cyclophosphamide increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to Cyclophosphamide and CYP2B1 results in increased susceptibility to Cyclophosphamide CTD PMID:10415877 more ... cyclophosphamide affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Cyclophosphamide CTD PMID:19103281 cyclophosphamide increases activity EXP 6480464 CYP2B1 results in increased activity of Cyclophosphamide CTD PMID:2272335 and PMID:9592392 cyclophosphamide increases hydroxylation EXP 6480464 CYP2B1 protein mutant form results in increased hydroxylation of Cyclophosphamide and CYP2B1 protein results in increased hydroxylation of Cyclophosphamide CTD PMID:11221871 and PMID:15102956 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of CYP2B1 mRNA and Cyclophosphamide results in increased expression of CYP2B1 protein CTD PMID:16019949 and PMID:17634551 cyclophosphamide increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Cyclophosphamide and CYP2B1 results in increased metabolism of Cyclophosphamide CTD PMID:15102956 and PMID:20566340 cyhalothrin increases activity EXP 6480464 cyhalothrin results in increased activity of CYP2B1 protein CTD PMID:29727961 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of CYP2B1 mRNA CTD PMID:29727961 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CYP2B1 mRNA CTD PMID:11377398 more ... cyproconazole increases activity EXP 6480464 cyproconazole results in increased activity of CYP2B1 protein CTD PMID:25182419 and PMID:29038839 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B1 mRNA more ... CTD PMID:29038839 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP2B1 mRNA CTD PMID:25182419 and PMID:29038839 DDD increases expression EXP 6480464 Dichlorodiphenyldichloroethane results in increased expression of CYP2B1 mRNA CTD PMID:21259292 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP2B1 more ... CTD PMID:12869653 and PMID:21512963 DDT multiple interactions EXP 6480464 [DDT co-treated with Diethylnitrosamine] results in decreased expression of CYP2B1 mRNA and [DDT co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA CTD PMID:15885732 DDT increases activity EXP 6480464 DDT results in increased activity of CYP2B1 protein CTD PMID:1372805 DDT increases expression EXP 6480464 DDT results in increased expression of CYP2B1 protein CTD PMID:11948501 more ... decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CYP2B1 mRNA and decabromobiphenyl ether results in increased expression of CYP2B1 protein CTD PMID:18495385 more ... decabromodiphenyl ether increases activity EXP 6480464 decabromobiphenyl ether results in increased activity of CYP2B1 protein CTD PMID:18495385 deoxycholic acid multiple interactions EXP 6480464 Deoxycholic Acid results in decreased expression of and results in decreased activity of CYP2B1 protein and Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of and results in decreased activity of CYP2B1 protein] CTD PMID:10453939 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [2 more ... CTD PMID:2105156 and PMID:23770461 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP2B1 mRNA CTD PMID:11328961 more ... dextran sulfate decreases activity EXP 6480464 Dextran Sulfate results in decreased activity of CYP2B1 protein CTD PMID:28438436 dextran sulfate multiple interactions EXP 6480464 [Dextran Sulfate results in decreased activity of CYP2B1 protein] which results in decreased chemical synthesis of hydroxybupropion CTD PMID:28438436 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of CYP2B1 mRNA and allyl sulfide results in increased expression of CYP2B1 protein CTD PMID:10945841 more ... Diallyl sulfide increases activity EXP 6480464 allyl sulfide results in increased activity of CYP2B1 protein CTD PMID:1372805 Diallyl sulfide multiple interactions EXP 6480464 NR1I3 protein promotes the reaction [allyl sulfide results in increased expression of CYP2B1 mRNA] CTD PMID:11752103 diallyl trisulfide multiple interactions EXP 6480464 diallyl trisulfide inhibits the reaction [n-hexane results in increased activity of CYP2B1 protein] CTD PMID:28115069 diazepam increases expression EXP 6480464 Diazepam results in increased expression of CYP2B1 protein CTD PMID:16684660 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CYP2B1 mRNA and Dibutyl Phthalate results in increased expression of CYP2B1 protein CTD PMID:15901914 dibutyl phthalate decreases activity EXP 6480464 Dibutyl Phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 dicofol increases expression EXP 6480464 Dicofol results in increased expression of CYP2B1 protein CTD PMID:19595748 Dicyclohexyl phthalate decreases activity EXP 6480464 dicyclohexyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 diethyl phthalate decreases activity EXP 6480464 diethyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 diethyldithiocarbamic acid increases expression EXP 6480464 Ditiocarb results in increased expression of CYP2B1 mRNA CTD PMID:8390837 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CYP2B1 mRNA CTD PMID:7513451 Dimethyl phthalate decreases activity EXP 6480464 dimethyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 dimethyl sulfoxide multiple interactions EXP 6480464 Dimethyl Sulfoxide inhibits the reaction [CYP2B1 protein results in increased metabolism of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19858067 dimethylarsinic acid multiple interactions EXP 6480464 [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA and [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein CTD PMID:12115560 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of CYP2B1 mRNA CTD PMID:17481689 dioxygen multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP2B1 protein more ... CTD PMID:26747958 dioxygen decreases activity EXP 6480464 Oxygen deficiency results in decreased activity of CYP2B1 protein CTD PMID:32416225 dipropyl phthalate decreases activity EXP 6480464 di-n-propylphthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 disulfiram multiple interactions EXP 6480464 GH1 protein inhibits the reaction [Disulfiram results in increased expression of CYP2B1 mRNA] CTD PMID:8390837 disulfiram increases expression EXP 6480464 Disulfiram results in increased expression of CYP2B1 mRNA CTD PMID:8390837 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of CYP2B1 mRNA CTD PMID:29391264 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CYP2B1 mRNA CTD PMID:25182419 and PMID:29038839 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B1 mRNA more ... CTD PMID:29038839 epoxiconazole increases activity EXP 6480464 epoxiconazole results in increased activity of CYP2B1 protein CTD PMID:25182419 and PMID:29038839 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP2B1 mRNA and Ethanol results in increased expression of CYP2B1 protein CTD PMID:23273579 more ... ethanol multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP2B1 protein more ... CTD PMID:26747958 and PMID:35301062 ethylbenzene increases expression EXP 6480464 ethylbenzene results in increased expression of CYP2B1 protein CTD PMID:1417939 and PMID:8135039 ethylparaben decreases activity EXP 6480464 ethyl-p-hydroxybenzoate results in decreased activity of CYP2B1 protein CTD PMID:27432241 farnesol increases activity EXP 6480464 Farnesol results in increased activity of CYP2B1 protein CTD PMID:15840382 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of CYP2B1 mRNA CTD PMID:19118567 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of CYP2B1 mRNA CTD PMID:11377398 fipronil increases expression EXP 6480464 fipronil results in increased expression of CYP2B1 mRNA CTD PMID:23962444 fluoren-9-one increases expression EXP 6480464 9-fluorenone results in increased expression of CYP2B1 protein CTD PMID:10445401 fluorene increases expression EXP 6480464 fluorene results in increased expression of CYP2B1 protein CTD PMID:10445401 gadolinium trichloride multiple interactions EXP 6480464 gadolinium chloride inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] more ... CTD PMID:10918498 and PMID:18202523 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of CYP2B1 mRNA and Hexachlorocyclohexane results in increased expression of CYP2B1 protein CTD PMID:11684361 more ... gamma-hexachlorocyclohexane multiple interactions EXP 6480464 Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP2B1 protein more ... CTD PMID:18486174 gamma-hexachlorocyclohexane increases activity EXP 6480464 Hexachlorocyclohexane results in increased activity of CYP2B1 protein CTD PMID:11684361 and PMID:12842176 gamma-terpinene decreases activity EXP 6480464 gamma-terpinene results in decreased activity of CYP2B1 protein CTD PMID:9242356 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CYP2B1 mRNA CTD PMID:33387578 geranial decreases activity EXP 6480464 citral results in decreased activity of CYP2B1 protein CTD PMID:9242356 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP2B1 mRNA CTD PMID:24136188 GW 7647 multiple interactions EXP 6480464 GW 7647 promotes the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:19631232 hemin multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP2B1 protein more ... CTD PMID:26747958 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of CYP2B1 protein CTD PMID:10696772 hexane multiple interactions EXP 6480464 diallyl trisulfide inhibits the reaction [n-hexane results in increased activity of CYP2B1 protein] CTD PMID:28115069 hexane increases activity EXP 6480464 n-hexane results in increased activity of CYP2B1 protein CTD PMID:28115069 hydrogen peroxide multiple interactions EXP 6480464 Hydrogen Peroxide inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:11353799 hydroquinone multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone CTD PMID:8211999 Hydroxybupropion multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Bupropion] which results in increased chemical synthesis of hydroxybupropion and [Dextran Sulfate results in decreased activity of CYP2B1 protein] which results in decreased chemical synthesis of hydroxybupropion CTD PMID:28438436 Hydroxybupropion increases chemical synthesis EXP 6480464 CYP2B1 protein results in increased chemical synthesis of hydroxybupropion CTD PMID:28438436 ifosfamide multiple interactions EXP 6480464 [CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil] more ... CTD PMID:10415877 more ... ifosfamide increases response to substance EXP 6480464 CYP2B1 results in increased susceptibility to Ifosfamide CTD PMID:10415877 more ... ifosfamide increases activity EXP 6480464 CYP2B1 results in increased activity of Ifosfamide CTD PMID:2272335 and PMID:9592392 ifosfamide increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Ifosfamide and CYP2B1 results in increased metabolism of Ifosfamide CTD PMID:10415877 and PMID:15102956 ifosfamide increases hydroxylation EXP 6480464 CYP2B1 protein mutant form results in increased hydroxylation of Ifosfamide CTD PMID:15102956 indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of CYP2B1 and indole-3-carbinol results in increased expression of CYP2B1 protein CTD PMID:8384853 and PMID:9806166 Isosafrole multiple interactions EXP 6480464 isosafrole promotes the reaction [CYP2B1 protein results in increased oxidation of Thiotepa] CTD PMID:2105156 ketamine increases expression EXP 6480464 Ketamine results in increased expression of CYP2B1 protein CTD PMID:16076768 ketoconazole multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP2B1 protein results in increased metabolism of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19858067 lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of CYP2B1 protein CTD PMID:9152597 limonene decreases activity EXP 6480464 limonene results in decreased activity of CYP2B1 protein CTD PMID:9242356 linuron affects activity EXP 6480464 Linuron affects the activity of CYP2B1 protein CTD PMID:7823289 m-tolualdehyde decreases activity EXP 6480464 3-methylbenzaldehyde results in decreased activity of CYP2B1 protein CTD PMID:12791539 m-xylene affects activity EXP 6480464 3-xylene affects the activity of CYP2B1 protein CTD PMID:15204773 and PMID:8296328 m-xylene decreases activity EXP 6480464 3-xylene results in decreased activity of CYP2B1 protein CTD PMID:12791539 more ... m-xylene increases expression EXP 6480464 3-xylene results in increased expression of CYP2B1 protein CTD PMID:8135039 m-xylene multiple interactions EXP 6480464 [3-xylene results in decreased activity of CYP2B1 protein] which affects the metabolism of Benzo(a)pyrene CTD PMID:1949897 mangiferin increases activity EXP 6480464 mangiferin results in increased activity of CYP2B1 protein CTD PMID:18053976 metazachlor increases expression EXP 6480464 metazachlor results in increased expression of CYP2B1 mRNA CTD PMID:31465819 methoxsalen decreases activity EXP 6480464 Methoxsalen results in decreased activity of CYP2B1 protein CTD PMID:15879494 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CYP2B1 mRNA and Methoxychlor results in increased expression of CYP2B1 protein CTD PMID:14613717 more ... methoxychlor decreases methylation EXP 6480464 CYP2B1 protein results in decreased methylation of Methoxychlor CTD PMID:12433799 and PMID:7895613 methoxychlor increases hydroxylation EXP 6480464 CYP2B1 protein results in increased hydroxylation of Methoxychlor CTD PMID:7895613 methylarsonic acid multiple interactions EXP 6480464 [monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA and [monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein CTD PMID:12115560 methylarsonic acid increases expression EXP 6480464 monomethylarsonic acid results in increased expression of CYP2B1 mRNA CTD PMID:17481689 metolachlor increases activity EXP 6480464 metolachlor results in increased activity of CYP2B1 protein CTD PMID:10813365 metyrapone multiple interactions EXP 6480464 Metyrapone inhibits the reaction [CYP2B1 results in increased susceptibility to Cyclophosphamide] and Metyrapone inhibits the reaction [CYP2B1 results in increased susceptibility to Ifosfamide] CTD PMID:7834628 metyrapone increases expression EXP 6480464 Metyrapone results in increased expression of CYP2B1 mRNA CTD PMID:16125621 mifepristone increases expression EXP 6480464 Mifepristone results in increased expression of CYP2B1 mRNA CTD PMID:16125621 mirex increases expression EXP 6480464 Mirex results in increased expression of CYP2B1 mRNA and Mirex results in increased expression of CYP2B1 protein CTD PMID:1715015 mitomycin C multiple interactions EXP 6480464 Mitomycin affects the reaction [CYP2B1 results in increased susceptibility to Ifosfamide] CTD PMID:10415877 monobenzyl phthalate decreases activity EXP 6480464 mono-benzyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 Monobutylphthalate decreases activity EXP 6480464 monobutyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 musk xylene affects activity EXP 6480464 musk xylene affects the activity of CYP2B1 protein CTD PMID:10630706 musk xylene increases expression EXP 6480464 musk xylene results in increased expression of CYP2B1 mRNA and musk xylene results in increased expression of CYP2B1 protein CTD PMID:10630706 N'-(2,4-dimethylphenyl)-N-methylformamidine increases expression EXP 6480464 U 40481 results in increased expression of CYP2B1 protein CTD PMID:31029719 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of CYP2B1 gene CTD PMID:33148267 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine promotes the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:11353799 and PMID:14722249 N-Nitrosodi-n-butylamine increases hydroxylation EXP 6480464 CYP2B1 protein results in increased hydroxylation of dibutylnitrosamine CTD PMID:8625499 N-Nitrosodi-n-propylamine increases hydroxylation EXP 6480464 CYP2B1 protein results in increased hydroxylation of N-nitroso(di-n-propyl)amine CTD PMID:8625499 N-Nitrosodi-n-propylamine decreases nitrosation EXP 6480464 CYP2B1 protein results in decreased nitrosation of N-nitroso(di-n-propyl)amine CTD PMID:10910959 N-Nitrosodi-n-propylamine affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of N-nitroso(di-n-propyl)amine CTD PMID:10910959 N-nitrosodiethylamine multiple interactions EXP 6480464 [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA more ... CTD PMID:10550479 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CYP2B1 mRNA CTD PMID:21763762 N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CYP2B1 mRNA CTD PMID:22037397 NADP zwitterion multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with NADP] results in decreased activity of CYP2B1 protein CTD PMID:11805216 and PMID:16485904 NADP(+) multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with NADP] results in decreased activity of CYP2B1 protein CTD PMID:11805216 and PMID:16485904 nevirapine increases expression EXP 6480464 Nevirapine metabolite results in increased expression of CYP2B1 mRNA and Nevirapine results in increased expression of CYP2B1 mRNA CTD PMID:23947594 nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 2 more ... CTD PMID:10799646 more ... nicotine increases expression EXP 6480464 Nicotine results in increased expression of CYP2B1 mRNA and Nicotine results in increased expression of CYP2B1 protein CTD PMID:10799646 and PMID:14972772 nicotine increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Nicotine CTD PMID:10799646 o-xylene decreases activity EXP 6480464 2-xylene results in decreased activity of CYP2B1 protein CTD PMID:7990171 octamethylcyclotetrasiloxane increases expression EXP 6480464 octamethylcyclotetrasiloxane results in increased expression of CYP2B1 protein CTD PMID:15849718 octamethylcyclotetrasiloxane multiple interactions EXP 6480464 octamethylcyclotetrasiloxane results in increased expression of and results in increased activity of CYP2B1 protein CTD PMID:36100151 okadaic acid multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [2 more ... CTD PMID:23770461 oltipraz affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of oltipraz CTD PMID:15831204 and PMID:15920769 omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP2B1 mRNA and Omeprazole results in increased expression of CYP2B1 protein CTD PMID:19118567 and PMID:9152597 oxazepam increases expression EXP 6480464 Oxazepam results in increased expression of CYP2B1 protein CTD PMID:16684660 p-xylene increases expression EXP 6480464 4-xylene results in increased expression of CYP2B1 protein CTD PMID:8135039 pantoprazole increases expression EXP 6480464 pantoprazole results in increased expression of CYP2B1 protein CTD PMID:9152597 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP2B1 protein CTD PMID:18798224 paracetamol multiple interactions EXP 6480464 Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP2B1 protein] CTD PMID:18798224 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CYP2B1 mRNA CTD PMID:32680482 parathion affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Parathion CTD PMID:16326433 parathion multiple interactions EXP 6480464 Parathion inhibits the reaction [Phenobarbital results in increased activity of CYP2B1 protein] CTD PMID:15690761 parathion-methyl multiple interactions EXP 6480464 CYP2B1 protein affects the reaction [Methyl Parathion results in decreased activity of ACHE protein] CTD PMID:11684353 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23770461 PCB138 multiple interactions EXP 6480464 NR1I2 gene mutant form inhibits the reaction [2 more ... CTD PMID:23770461 PCB138 increases activity EXP 6480464 2 more ... CTD PMID:15093247 pentachlorobenzene increases expression EXP 6480464 pentachlorobenzene results in increased expression of CYP2B1 protein CTD PMID:10696772 pentane-2,3-dione decreases expression EXP 6480464 2 and 3-pentanedione results in decreased expression of CYP2B1 mRNA CTD PMID:25710175 pentobarbital increases expression EXP 6480464 Pentobarbital results in increased expression of CYP2B1 mRNA and Pentobarbital results in increased expression of CYP2B1 protein CTD PMID:15655285 and PMID:8205533 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of CYP2B1 mRNA CTD PMID:34460931 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid analog results in increased expression of CYP2B1 protein CTD PMID:22245121 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP2B1 mRNA and perfluorooctanoic acid results in increased expression of CYP2B1 protein CTD PMID:20614104 and PMID:28511854 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of CYP2B1 gene more ... CTD PMID:11377398 more ... permethrin increases expression EXP 6480464 Permethrin results in increased expression of CYP2B1 mRNA CTD PMID:11377398 and PMID:14722249 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP2B1 mRNA CTD PMID:20360939 phenethyl caffeate decreases expression EXP 6480464 caffeic acid phenethyl ester results in decreased expression of CYP2B1 protein CTD PMID:22291063 phenformin increases expression EXP 6480464 Phenformin results in increased expression of CYP2B1 mRNA CTD PMID:31324951 phenobarbital multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide co-treated with Phenobarbital] results in increased expression of CYP2B1 mRNA] more ... CTD PMID:10215695 more ... phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP2B1 more ... CTD PMID:10036216 more ... phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of CYP2B1 protein CTD PMID:12458634 more ... phenol multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of Phenol CTD PMID:8211999 phenytoin decreases expression EXP 6480464 Phenytoin results in decreased expression of CYP2B1 mRNA CTD PMID:9819145 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of CYP2B1 mRNA CTD PMID:10945841 phorone increases activity EXP 6480464 phorone results in increased activity of CYP2B1 protein CTD PMID:7697745 phoxim increases expression EXP 6480464 phoxim results in increased expression of CYP2B1 mRNA CTD PMID:36356836 pioglitazone increases expression EXP 6480464 pioglitazone results in increased expression of CYP2B1 mRNA CTD PMID:16597547 piperonyl butoxide multiple interactions EXP 6480464 [Permethrin co-treated with Piperonyl Butoxide] results in increased expression of CYP2B1 mRNA and Piperonyl Butoxide inhibits the reaction [Permethrin results in increased expression of CYP2B1 mRNA] CTD PMID:11377398 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CYP2B1 mRNA CTD PMID:20735435 pirinixic acid multiple interactions EXP 6480464 pirinixic acid promotes the reaction [Phenobarbital results in increased activity of CYP2B1 protein] and pirinixic acid promotes the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:18023279 and PMID:19631232 pregnenolone 16alpha-carbonitrile multiple interactions EXP 6480464 NR1I2 gene mutant form inhibits the reaction [Pregnenolone Carbonitrile results in increased expression of CYP2B1 mRNA] CTD PMID:29548889 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CYP2B1 mRNA CTD PMID:29548889 prochloraz increases activity EXP 6480464 prochloraz results in increased activity of CYP2B1 protein CTD PMID:25182419 and PMID:29038839 prochloraz multiple interactions EXP 6480464 [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein and [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP2B1 mRNA CTD PMID:29038839 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP2B1 mRNA CTD PMID:25182419 and PMID:29038839 propachlor increases activity EXP 6480464 propachlor results in increased activity of CYP2B1 protein CTD PMID:10813365 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP2B1 mRNA and propiconazole results in increased expression of CYP2B1 protein CTD PMID:15603923 more ... propylbenzene increases expression EXP 6480464 n-propylbenzene results in increased expression of CYP2B1 protein CTD PMID:8135039 propylparaben decreases activity EXP 6480464 propylparaben results in decreased activity of CYP2B1 protein CTD PMID:27432241 propyzamide increases expression EXP 6480464 pronamide results in increased expression of CYP2B1 mRNA CTD PMID:25846364 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of CYP2B1 mRNA CTD PMID:22431067 pyrene increases expression EXP 6480464 pyrene results in increased expression of CYP2B1 mRNA CTD PMID:30240548 pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of CYP2B1 mRNA CTD PMID:18022748 pyridine multiple interactions EXP 6480464 INS protein affects the reaction [pyridine results in increased expression of CYP2B1 mRNA] more ... CTD PMID:10215695 and PMID:7587954 pyridine increases expression EXP 6480464 pyridine results in increased expression of CYP2B1 mRNA and pyridine results in increased expression of CYP2B1 protein CTD PMID:10215695 more ... pyridine increases activity EXP 6480464 pyridine results in increased activity of CYP2B1 protein CTD PMID:11181506 and PMID:1610360 pyridine affects activity EXP 6480464 pyridine affects the activity of CYP2B1 protein CTD PMID:8246169 reactive oxygen species increases abundance EXP 6480464 CYP2B1 results in increased abundance of Reactive Oxygen Species CTD PMID:20407477 reactive oxygen species multiple interactions EXP 6480464 [tetrabromobisphenol A results in increased expression of CYP2B1 protein] which results in increased abundance of Reactive Oxygen Species CTD PMID:24278553 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP2B1 mRNA CTD PMID:25905778 Retrorsine increases expression EXP 6480464 retrorsine results in increased expression of CYP2B1 CTD PMID:24799337 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP2B1 mRNA CTD PMID:28374803 sanguinarine decreases activity EXP 6480464 sanguinarine results in decreased activity of CYP2B1 protein CTD PMID:19788401 Shikonin decreases activity EXP 6480464 shikonin results in decreased activity of CYP2B1 protein CTD PMID:28941798 sodium arsenite multiple interactions EXP 6480464 sodium arsenite inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:10329507 sodium chromate multiple interactions EXP 6480464 Carbon Monoxide inhibits the reaction [CYP2B1 protein results in increased reduction of sodium chromate(VI)] and Carbon Tetrachloride inhibits the reaction [CYP2B1 protein results in increased reduction of sodium chromate(VI)] CTD PMID:1903091 sodium chromate increases reduction EXP 6480464 CYP2B1 protein results in increased reduction of sodium chromate(VI) CTD PMID:1903091 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of CYP2B1 mRNA CTD PMID:22561333 stilbene oxide increases expression EXP 6480464 stilbene oxide results in increased expression of CYP2B1 mRNA CTD PMID:10945841 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP2B1 mRNA CTD PMID:25905778 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CYP2B1 mRNA CTD PMID:25905778 strychnine multiple interactions EXP 6480464 Strychnine results in increased expression of and results in increased degradation of CYP2B1 protein CTD PMID:7906730 styrene multiple interactions EXP 6480464 gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2B1 mRNA] and gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2B1 protein] CTD PMID:18202523 styrene increases expression EXP 6480464 Styrene results in increased expression of CYP2B1 mRNA and Styrene results in increased expression of CYP2B1 protein CTD PMID:16418063 and PMID:18202523 styrene oxide multiple interactions EXP 6480464 CYP2B1 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] CTD PMID:12051674 Sudan III multiple interactions EXP 6480464 [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B1 protein] more ... CTD PMID:15788368 Sudan III decreases expression EXP 6480464 sudan III results in decreased expression of CYP2B1 mRNA CTD PMID:15788368 sulfoxaflor increases expression EXP 6480464 sulfoxaflor results in increased expression of CYP2B1 mRNA CTD PMID:23607986 tacrine increases expression EXP 6480464 Tacrine analog results in increased expression of CYP2B1 protein and Tacrine results in increased expression of CYP2B1 protein CTD PMID:20533758 tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of CYP2B1 protein CTD PMID:29923317 tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of CYP2B1 mRNA CTD PMID:24090815 testosterone affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Testosterone CTD PMID:15879494 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of CYP2B1 protein CTD PMID:7726643 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP2B1 mRNA and Carbon Tetrachloride results in decreased expression of CYP2B1 protein CTD PMID:10445401 and PMID:32380060 tetrachloromethane multiple interactions EXP 6480464 Carbon Tetrachloride inhibits the reaction [CYP2B1 protein results in increased reduction of sodium chromate(VI)] CTD PMID:1903091 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYP2B1 protein CTD PMID:17606319 Tetramethylthiourea increases expression EXP 6480464 tetramethylthiourea results in increased expression of CYP2B1 protein CTD PMID:10190572 thiabendazole increases expression EXP 6480464 Thiabendazole results in increased expression of CYP2B1 mRNA and Thiabendazole results in increased expression of CYP2B1 protein CTD PMID:15110098 thiophanate-methyl affects expression EXP 6480464 Thiophanate affects the expression of CYP2B1 protein CTD PMID:10096430 Thiotepa increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of Thiotepa CTD PMID:2105156 Thiotepa multiple interactions EXP 6480464 Clofibrate promotes the reaction [CYP2B1 protein results in increased oxidation of Thiotepa] more ... CTD PMID:2105156 toluene increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of Toluene CTD PMID:1994898 toluene increases expression EXP 6480464 Toluene results in increased expression of CYP2B1 protein CTD PMID:8135039 toluene multiple interactions EXP 6480464 [Phenobarbital results in increased expression of CYP2B1 protein] which results in increased metabolism of Toluene and Phenobarbital promotes the reaction [CYP2B1 protein results in increased oxidation of Toluene] CTD PMID:1994898 and PMID:9010585 toluene 2,4-diisocyanate decreases expression EXP 6480464 Toluene 2 more ... CTD PMID:11043495 toluene 2,4-diisocyanate increases expression EXP 6480464 Toluene 2 and 4-Diisocyanate results in increased expression of CYP2B1 CTD PMID:12415424 trans-1,2-dichloroethene affects expression EXP 6480464 1 and 2-dichloroethylene affects the expression of CYP2B1 protein CTD PMID:9493318 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP2B1 mRNA and triadimefon results in increased expression of CYP2B1 protein CTD PMID:17178689 and PMID:17484520 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CYP2B1 mRNA CTD PMID:33387578 triclosan increases expression EXP 6480464 Triclosan results in increased expression of CYP2B1 and Triclosan results in increased expression of CYP2B1 mRNA CTD PMID:19910387 more ... trimethylarsine oxide multiple interactions EXP 6480464 [trimethylarsine oxide co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA and [trimethylarsine oxide co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein CTD PMID:12115560 trimethylarsine oxide increases expression EXP 6480464 trimethylarsine oxide results in increased expression of CYP2B1 mRNA CTD PMID:17481689 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CYP2B1 mRNA CTD PMID:30589522 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of CYP2B1 mRNA CTD PMID:33600922 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP2B1 mRNA CTD PMID:16597547 uranium atom increases expression EXP 6480464 Uranium results in increased expression of CYP2B1 mRNA CTD PMID:16039771 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of and results in decreased activity of CYP2B1 protein] CTD PMID:10453939 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CYP2B1 mRNA CTD PMID:24136188 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP2B1 protein CTD PMID:7986207 zinc protoporphyrin multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP2B1 protein CTD PMID:26747958
